{
    "id": 7230,
    "name": "postgerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma",
    "source": "DOID",
    "definition": null,
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:7230",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02251548",
            "title": "A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia",
            "phase": "Phase II",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 2185,
                    "therapyName": "Cyclophosphamide + Fludarabine + Ibrutinib + Rituximab",
                    "synonyms": null
                }
            ]
        }
    ]
}